NASDAQ:KIDS

OrthoPediatrics Q3 2024 Earnings Results & Report

OrthoPediatrics logo
$31.65 +0.24 (+0.76%)
Closing price 04:00 PM Eastern
Extended Trading
$31.69 +0.04 (+0.13%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics reported Q3 2024 earnings on January 14, 2025. The company reported EPS of -$0.18, while revenue was $54.57 million.

Earnings Announcement Details

Quarter
Q3 2024
Report Date
Time
After Market Closes

OrthoPediatrics EPS Results

Actual EPS
-$0.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
6 of last 8 quarters

OrthoPediatrics Revenue Results

Actual Revenue
$54.57 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

OrthoPediatrics Q3 2024 Earnings FAQ

OrthoPediatrics (NASDAQ:KIDS) reported earnings of -$0.18 per share for Q3 2024. The report was announced on Tuesday, January 14, 2025.

OrthoPediatrics reported revenue of $54.57 million for Q3 2024.

OrthoPediatrics Earnings Headlines

OrthoPediatrics to Participate in Upcoming Conferences
Your book is inside
Blane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn $100 Options Into $1,000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good.tc pixel
See More OrthoPediatrics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OrthoPediatrics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OrthoPediatrics and other key companies, straight to your email.

About OrthoPediatrics

OrthoPediatrics (NASDAQ:KIDS) develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders.

The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams.

Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics serves hospitals and surgeons in the United States and internationally through its sales network and distribution partners. The company focuses on addressing the distinct needs of growing children, whose bones and anatomy can require different treatment approaches from those used for adults.

View OrthoPediatrics Profile